EDX Medical confirms date for 2025 Annual General Meeting

EDX Medical Group Plc (AQSE: EDX), which develops innovative digital diagnostic products and services supporting personalised treatments for cancer, heart disease and infectious diseases, has announced that its annual general meeting (AGM) will be held at the Marcus Beck Library, 3rd Floor, Royal School of Medicine, 1 Wimpole Street, Westminster, London, W1G 0AE on 29 September 2025 at 2:00 p.m.

The annual report and financial statements for the year ended 31 March 2025, Notice of AGM and Form of Proxy will be posted today, 1 September 2025, to eligible shareholders. Electronic copies will be shortly available on the Company’s website at: https://edxmedical.co.uk/documents/

Share on:

Written by: Amilia Stone

Find more news, interviews, share price & company profile here for:
EDX Medical Group plc

Latest Company News

EDX Medical backs large-scale prostate cancer testing in Scotland

June 10, 2026

EDX Medical is supporting a Scottish prostate cancer testing programme for 25,000 men, strengthening its position in early cancer detection and practical diagnostic services.

AIM admission marks new phase for EDX Medical’s diagnostic expansion

June 3, 2026

EDX Medical has joined AIM as it advances the commercial rollout of diagnostic tests targeting cancer and other major diseases, supported by growing clinical screening programmes.

EDX Medical targets AIM growth with ultra-accurate cancer diagnostics

May 20, 2026

EDX Medical Chief Scientific Officer Professor Chris Evans discusses the company’s AIM admission, prostate cancer testing programme in Scotland, and plans to commercialise a range of advanced diagnostic tests.

EDX Medical begins trading on AIM following move from Aquis

May 13, 2026

EDX Medical has commenced trading on the AIM market of the London Stock Exchange under the ticker EDX, highlighting its growth strategy in cancer and infectious disease diagnostics and its expanding portfolio of personalised healthcare technologies.

EDX Medical seeks AIM admission as it prepares to leave Aquis

April 13, 2026

EDX Medical has announced plans to transfer its ordinary shares from the Aquis Stock Exchange to AIM, with admission and withdrawal expected to take effect simultaneously on 13 May 2026. The company says the move is intended to improve access to growth capital, investor visibility and share liquidity.

EDX Medical to lead Scottish Prostate Cancer Testing Initiative

March 25, 2026

EDX Medical will serve as the primary delivery partner for the Scottish Prostate Cancer Initiative, which plans to offer free PSA testing to 25,000 men across Scotland and explore ways to improve early detection and diagnosis of the disease.

EDX Medical confirms date for 2025 Annual General Meeting

We’ll keep you in the loop!

Latest Company News

Search

Follow us on Social Media: